2018_MER_LOGO_TM_BLU_sm.jpg
Meridian submits Curian™ analyzer and the Curian™ HpSA assay to the FDA
06 nov. 2019 07h30 HE | Meridian Bioscience Inc.
CINCINNATI, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has submitted Curian™ and the Curian™ HpSA assay to the FDA for review. This platform...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Bioscience to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on November 7, 2019
16 oct. 2019 11h00 HE | Meridian Bioscience Inc.
CINCINNATI, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials will report fourth quarter and full...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Bioscience Reports Third Quarter 2019 Operating Results
30 juil. 2019 07h30 HE | Meridian Bioscience Inc.
CINCINNATI, Ohio, July 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter and first nine months ended June 30, 2019. Third...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Bioscience to Hold Third Quarter 2019 Financial Results Conference Call on July 30, 2019
10 juil. 2019 16h30 HE | Meridian Bioscience Inc.
CINCINNATI, July 10, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials will report third quarter 2019...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Bioscience Announces Closing of Transaction to Acquire Business of GenePOC
03 juin 2019 16h28 HE | Meridian Bioscience Inc.
CINCINNATI, June 03, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has completed...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition
30 avr. 2019 09h42 HE | Meridian Bioscience Inc.
CINCINNATI, April 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter and first six months ended March 31, 2019. Second...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics Platform
30 avr. 2019 09h41 HE | Meridian Bioscience Inc.
CINCINNATI, April 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has entered...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Launches a New Inhibitor Tolerant qPCR Reagent to Significantly Simplify Molecular Diagnostic Workflows From Crude Samples
18 avr. 2019 08h48 HE | Meridian Bioscience Inc.
CINCINNATI, April 18, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced the launch of its Inhibitor-tolerant qPCR Mix, a novel mix to accelerate workflows and improve...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Bioscience to Hold Second Quarter 2019 Financial Results Conference Call on April 30, 2019
10 avr. 2019 16h55 HE | Meridian Bioscience Inc.
CINCINNATI, April 10, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials will report second quarter 2019...
2018_MER_LOGO_TM_BLU_sm.jpg
Meridian Bioscience Announces Preliminary Second Quarter 2019 Revenue Results; Updates Fiscal 2019 Guidance
02 avr. 2019 06h59 HE | Meridian Bioscience Inc.
CINCINNATI, April 02, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided a business update...